back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-17 15:40 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,000
+100,000 vol $0.10 each |
406,000 | |
| Filed 2026-06-17 15:39 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
350,000 | |
| Filed 2026-06-17 15:30 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
700,000 | |
| Filed 2026-06-17 15:29 Tx date 2026-06-15 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
450,000 | |
| Older filings | ||||||
| Filed 2026-06-12 13:29 Tx date 2026-06-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$17,500
+175,000 vol $0.10 each |
6,077,778 | |
| Filed 2026-06-12 13:28 Tx date 2026-06-10 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-17,500
-175,000 vol $0.10 each |
3,000,000 | |
| Filed 2026-05-21 14:21 Tx date 2026-05-08 |
$MDMA
Pharmala Biotech Holdings Inc. |
Ryer, Lennie
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,400
+36,000 vol $0.15 each |
36,000 | |
| Filed 2026-05-21 14:20 Tx date 2026-02-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
Ryer, Lennie
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-05-15 10:58 Tx date 2026-05-14 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,000
+100,000 vol $0.10 each |
456,000 | |
| Filed 2026-05-15 10:58 Tx date 2026-05-14 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,000
-100,000 vol $0.10 each |
350,000 | |
| Filed 2026-04-30 13:04 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
5,902,778 | |
| Filed 2026-04-30 13:04 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
0 | |
| Filed 2026-04-30 12:59 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+750,000 vol |
1,000,000 | |
| Filed 2026-04-30 12:58 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-750,000 vol |
0 | |
| Filed 2026-04-30 12:57 Tx date 2026-04-20 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Indirect Ownership)
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,100,000 | |
| Filed 2026-04-30 12:56 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Indirect Ownership)
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2026-04-30 12:56 Tx date 2024-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-30 12:54 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+267 vol |
1,553 | |
| Filed 2026-04-30 12:53 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,286 vol |
1,286 | |
| Filed 2026-04-23 15:25 Tx date 2026-04-20 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
||